Casey Cunningham
Direktor/Vorstandsmitglied bei Lyric Pharmaceuticals, Inc.
Profil
Casey joined Santé Ventures in 2008 as Chief Scientific Officer and concentrates on the biotechnology space.
Before joining Santé, Casey had a long academic career, first as a faculty member at Harvard Medical School and then as the Associate Director of the Mary Crowley Cancer Research Center, an early phase clinical trial institute with an emphasis on gene and cell-based therapies.
He serves on numerous Advisory Boards, including MD Anderson, The City of Hope, and Baylor Medical School.
Casey is also on the National Board of the Leukemia and Lymphoma Society, where he chairs the Therapy Acceleration Program.
He has played operating roles in several Santé portfolio companies, acting as Chief Medical Officer.
Casey attended fellowship training in oncology and hematology at Massachusetts General Hospital after an internal medicine residency at the Medical College of Wisconsin, where he was also Chief Medical Resident.
He earned his MD from the University of Texas Southwestern Medical School and his BS in physics and biology from Texas A&M.
Aktive Positionen von Casey Cunningham
| Unternehmen | Position | Beginn |
|---|---|---|
Lyric Pharmaceuticals, Inc.
 Lyric Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Lyric Pharmaceuticals, Inc. operates as a clinical-stage pharmaceutical company. The firm develops novel gastrointestinal therapeutics for unmet medical needs in the hospital settings. The company was founded by David Wurtman and M. Scott Harris in 2013 and is headquartered in South San Fancisco, CA. | Direktor/Vorstandsmitglied | - |
Nirogy Therapeutics, Inc.
 Nirogy Therapeutics, Inc. BiotechnologyHealth Technology Nirogy Therapeutics, Inc. is an American biotechnology company that operates in the healthcare industry. The company is based in N/A. The company was founded in 2014 by Vincent Sandanayaka, Jaime Escobedo. Simon C. Pedder has been the CEO of the company since 2022. | Direktor/Vorstandsmitglied | - |
SHVMS, LLC
 SHVMS, LLC Investment ManagersFinance SHVMS, LLC (Sante Ventures) is a Venture Capital firm founded in 2006 by Joe Hal Cunningham, Kevin Myles Lalande and Doug Dewitt French. The firm is headquartered in Austin, Texas. | Private Equity Investor | 01.01.2008 |
Ehemalige bekannte Positionen von Casey Cunningham
| Unternehmen | Position | Ende |
|---|---|---|
Terapio Corp.
 Terapio Corp. Pharmaceuticals: MajorHealth Technology Terapio Corp. develops therapeutics based on the RLIP76 protein. The firm’s products are used in the areas of radiation countermeasure, chemical countermeasure and oncology supportive care. The company was founded by Casey Cunningham, Kevin Lalande and Sanjay Awasthi in 2005 and is headquartered in Austin, TX. | Vorstandsvorsitzender | - |
AbVitro LLC
 AbVitro LLC BiotechnologyHealth Technology AbVitro LLC provided an antibody discovery platform. The company was founded by George W. Church, Uri Laserson, Mirza Cifric and Francois Vigneault in 2010 and headquartered in Seattle, WA. | Direktor/Vorstandsmitglied | - |
Molecular Templates, Inc. /Old/
 Molecular Templates, Inc. /Old/ BiotechnologyHealth Technology Molecular Templates, Inc. operates as a holding company that engages in the discovery and development of immunotoxins for the treatment of cancer and other serious diseases. These are capable of targeting validated therapeutic cell surface receptors but also non-traditional targets that cannot be therapeutically targeted by antibodies or small molecules. Its product pipeline consists of lead candidates for non-Hodgkin's lymphoma, multiple myeloma, and breast cancer. The company was founded by Jean Gariépy and Leigh Revers in 2009 and is headquartered in Georgetown, TX. | Technik-/Wissenschafts-/F&E-Leiter | 25.02.2014 |
Ausbildung von Casey Cunningham
| The University of Texas at Austin | Undergraduate Degree |
| The University of Texas Southwestern Medical Center | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 6 |
|---|---|
Molecular Templates, Inc. /Old/
Molecular Templates, Inc. /Old/ BiotechnologyHealth Technology Molecular Templates, Inc. operates as a holding company that engages in the discovery and development of immunotoxins for the treatment of cancer and other serious diseases. These are capable of targeting validated therapeutic cell surface receptors but also non-traditional targets that cannot be therapeutically targeted by antibodies or small molecules. Its product pipeline consists of lead candidates for non-Hodgkin's lymphoma, multiple myeloma, and breast cancer. The company was founded by Jean Gariépy and Leigh Revers in 2009 and is headquartered in Georgetown, TX. | Health Technology |
Terapio Corp.
Terapio Corp. Pharmaceuticals: MajorHealth Technology Terapio Corp. develops therapeutics based on the RLIP76 protein. The firm’s products are used in the areas of radiation countermeasure, chemical countermeasure and oncology supportive care. The company was founded by Casey Cunningham, Kevin Lalande and Sanjay Awasthi in 2005 and is headquartered in Austin, TX. | Health Technology |
AbVitro LLC
AbVitro LLC BiotechnologyHealth Technology AbVitro LLC provided an antibody discovery platform. The company was founded by George W. Church, Uri Laserson, Mirza Cifric and Francois Vigneault in 2010 and headquartered in Seattle, WA. | Health Technology |
Lyric Pharmaceuticals, Inc.
Lyric Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Lyric Pharmaceuticals, Inc. operates as a clinical-stage pharmaceutical company. The firm develops novel gastrointestinal therapeutics for unmet medical needs in the hospital settings. The company was founded by David Wurtman and M. Scott Harris in 2013 and is headquartered in South San Fancisco, CA. | Health Technology |
Nirogy Therapeutics, Inc.
Nirogy Therapeutics, Inc. BiotechnologyHealth Technology Nirogy Therapeutics, Inc. is an American biotechnology company that operates in the healthcare industry. The company is based in N/A. The company was founded in 2014 by Vincent Sandanayaka, Jaime Escobedo. Simon C. Pedder has been the CEO of the company since 2022. | Health Technology |
SHVMS, LLC
SHVMS, LLC Investment ManagersFinance SHVMS, LLC (Sante Ventures) is a Venture Capital firm founded in 2006 by Joe Hal Cunningham, Kevin Myles Lalande and Doug Dewitt French. The firm is headquartered in Austin, Texas. | Finance |
